GeneDx

IPO

Empowering everyone to live their healthiest life through genomics

GeneDx is a biotech company in Stamford, United States, founded in 2000. It has raised $1.0B across 3 rounds, most recently a $200.0M Corporate Round in January 2022.

Employees
501–1000
Founded
2000
Business Model
B2B
Website
genedx.com
Total Funding
$1.0B
Last Round
$200.0M Corporate RoundJan 2022
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. to use credits for reveals, or explore the API.

About

GeneDx is a genomics company that provides comprehensive genetic testing for rare and undiagnosed conditions. Founded in 2000 by NIH scientists, GeneDx offers whole exome sequencing, whole genome sequencing, and targeted genetic panels to clinicians and patients worldwide. The company has diagnosed over 4,800 genetic diseases and published over 1,000 scientific papers. GeneDx trades on Nasdaq under the ticker WGS and is headquartered in Stamford, Connecticut.

Funding History

Data from Indexed.vcUpdated
Debt FinancingDebt FacilityFeb 2026
$100.0M

3 more funding events

  • Corporate Round2022
  • Corporate Round2021
  • Series C20204 investors

Funding: Series C through Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • Cloud/Infrastructure ×1
  • Product & Customer Success ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GeneDx on Indexed.vc
<a href="https://indexed.vc/companies/genedx"><img src="https://indexed.vc/api/badge/company/genedx" alt="GeneDx on Indexed.vc" width="260" height="76" /></a>